<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0001417'>X-linked</z:hpo> lymphoproliferative syndrome (XLP) is characterized by a combined variable <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> with vulnerability to Epstein-Barr virus (EBV)-induced fatal or <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e>, acquired <z:hpo ids='HP_0004432'>agammaglobulinemia</z:hpo>, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, or malignant B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Diagnosis of XLP requires documentation of two or more maternally related males with these phenotypes </plain></SENT>
<SENT sid="2" pm="."><plain>Epstein-Barr virus must be demonstrated in circulating blood, lymphoid tissues, or saliva of infected males </plain></SENT>
<SENT sid="3" pm="."><plain>Characteristically, the patients have low-titer antibodies to EBV and often lack anti-EB nuclear-associated antibody due to T cell defects </plain></SENT>
<SENT sid="4" pm="."><plain>Thymus gland is often depleted and epithelium may be destroyed </plain></SENT>
<SENT sid="5" pm="."><plain>Thymic-dependent regions in lymph nodes and spleen are depleted and <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> transformation with plasma cell differentiation is seen </plain></SENT>
<SENT sid="6" pm="."><plain>The carrier females exhibit partial <z:hpo ids='HP_0002721'>immune deficiency</z:hpo> and have paradoxically elevated antibodies to EBV </plain></SENT>
<SENT sid="7" pm="."><plain>Our registry of XLP provides consultation and comprehensive study of persons and families with the syndrome </plain></SENT>
</text></document>